Drug-labels.com

M-Betahistine: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
8 mg, 16 mg, 24 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - M-Betahistine

ABOUT THIS MEDICATION

What the medication is used for:

M-BETAHISTINE is used for reducing the episodes of recurrent vertigo (dizziness) associated with Ménière’s disease.

What it does:

M-BETAHISTINE is a type of medicine called a histamine- analogue. It is thought to work by helping the blood flow in your inner ear, which lowers the build up of pressure. It is this build up of pressure in the ear which is thought to cause feelings of dizziness (vertigo), feelings of being sick (nausea and vomiting), ringing in the ears (tinnitus), and hearing loss or hearing difficulty suffered by people with Ménière’s disease.

When it should not be used:

Do not take M-BETAHISTINE if:

  • you are allergic (hypersensitive) to betahistine dihydrochloride or to any of the non-medicinal ingredients in the product.
  • you have a peptic (stomach) ulcer or have a history of this condition.
  • your doctor has told you that you have an adrenal gland tumour (called phaeochromocytoma).

What the medicinal ingredient is:

Betahistine dihydrochloride

What the non-medicinal ingredients are:

Citric acid anhydrous, Colloidal silicon dioxide, Mannitol, Microcrystalline cellulose and Talc.

What dosage forms it comes in:

Tablets: 8 mg, 16 mg and 24 mg

WARNINGS AND PRECAUTIONS

BEFORE you use M-BETAHISTINE talk to your doctor, nurse or pharmacist if you:

  • have or have had health problems in the past.
  • you are taking medications, including ones you can take without a doctor’s prescription e.g. natural or herbal remedies.
  • suffer from bronchial asthma, since asthmatic patients should use M-BETAHISTINE with caution.
  • have liver problems.
  • are pregnant, plan to become pregnant, or are breastfeeding.

  • are less than 18 years old.

Driving and using machines: M-BETAHISTINE is not likely to affect your ability to drive or use tools or machinery. However, remember that the disease for which you are being treated (recurrent vertigo associated with Ménière’s disease) can make you feel dizzy or sick, and can affect your ability to drive and use machines. Do not drive or engage in hazardous activities if you are experiencing these symptoms.

INTERACTIONS WITH THIS MEDICATION

As with most medicines, interactions with other drugs are possible. Tell your doctor, nurse, or pharmacist about all the medicines you take, including drugs prescribed by other doctors, vitamins, minerals, natural supplements, or alternative medicines.

The following may interact with M-BETAHISTINE:

  • antihistamines - these may lower the effect of M-BETAHISTINE. In addition, M-BETAHISTINE may lower the effect of antihistamines.
  • monoamine-oxidase inhibitors (MAOIs) - used to treat depression or Parkinson’s Disease. These may increase the amount of M-BETAHISTINE available in your bloodstream and your doctor may have to change your dose of M-BETAHISTINE.
PROPER USE OF THIS MEDIATION

It is very important to take M-BETAHISTINE exactly as your doctor has instructed. If you are not sure when or how many tablets to take each day, check with your doctor, nurse or pharmacist. It is recommended to take your dose at about the same time every day. M-BETAHISTINE is not recommended for use in children below 18 years of age.

M-BETAHISTINE can be taken with or without food. If M-BETAHISTINE causes upset stomach, take it with meals.

Usual adult dose:

The usual daily dose is 24 to 48 mg daily in divided doses.

M-BETAHISTINE 8 mg tablets – one to two tablets three times a day,

M-BETAHISTINE 16 mg tablets – half to one tablet three times a day,

or

M-BETAHISTINE 24 mg tablets – one tablet twice a day.

Overdose:

If you think you, or a person you are caring for, have taken too much M-BETAHISTINE, contact a healthcare professional, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If you forget a dose, skip the missed dose. Take your next dose at the usual time. Do not take a double dose to make up for a forgotten dose.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medicines, M-BETAHISTINE can cause side effects in some people. Most people have few or no side effects from betahistine dihydrochloride. Side effects that do occur tend to be generally mild and do not last a long time.

Side effects include:

  • skin rashes and itching
  • stomach pain
  • nausea, vomiting
  • bloating, indigestion
  • headache

After the release of betahistine dihydrochloride on the market, there were few reports of patients experiencing drowsiness, heart palpitations or light- headedness, faintness or dizziness from a drop in blood pressure during treatment with betahistine dihydrochloride. It is unclear whether they resulted from the use of betahistine dihydrochloride or other unrelated factors.

If any of these affect you severely, tell your doctor, nurse or pharmacist.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom/effectTalk with your doctor, nurse or pharmacistStop taking drug and seek immediate medical attention
Only if severeIn all cases
RareSevere allergic reaction: rash, hives, itching, swelling of the face, lips, tongue or throat, difficulty swallowing or breathing√

This is not a complete list of side effects. For any unexpected effects while taking M-BETAHISTINE, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

Store at room temperature 15°C to 30°C. Keep in a tightly closed container to protect from moisture. Protect from light.

Keep out of reach and sight of children.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about M-BETAHISTINE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this consumer information by visiting the Health Canada website (https://www.canada.ca/en/health- canada/services/drugs-health-products/drug- products/drug-product-database.html); or by contacting Mantra Pharma Inc. at medinfo@mantrapharma.ca or at 1-833-248-7326.

Mantra Pharma Inc.

9150 Boulevard Leduc, Suite 201

Brossard, QC, Canada

J4Y 0E3

Date of Preparation: August 25, 2021

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02519682

Revision date stated in the text: August 25, 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for M-Betahistine

Rx or OTC
Prescription (Rx)?
DIN 02519682, 02519690, 02519704
Schedule(s) PRESCRIPTION
Active ingredient(s) Betahistine hydrochloride
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N07 Other nervous system drugs
      1. N07C Antivertigo preparations
        1. N07CA Antivertigo preparations
          1. N07CA01 Betahistine
Company MANTRA PHARMA INC
Current status Marketed
Strengths and forms
DIN Strength Dosage form(s) Current status
02519682 8 MG Tablet Marketed July 27, 2022
02519690 16 MG Tablet Marketed July 25, 2022
02519704 24 MG Tablet Marketed July 25, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.